GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 23 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | +25.0% | 1,815 | +46.3% | 0.00% | – |
Q2 2021 | $4,000 | -55.6% | 1,241 | -51.7% | 0.00% | – |
Q1 2021 | $9,000 | -65.4% | 2,568 | -69.1% | 0.00% | -100.0% |
Q4 2020 | $26,000 | -25.7% | 8,301 | -17.2% | 0.00% | – |
Q3 2020 | $35,000 | +600.0% | 10,027 | +547.7% | 0.00% | – |
Q1 2020 | $5,000 | -86.5% | 1,548 | -75.5% | 0.00% | -100.0% |
Q4 2019 | $37,000 | -2.6% | 6,328 | +21.5% | 0.00% | 0.0% |
Q2 2019 | $38,000 | +660.0% | 5,207 | +796.2% | 0.00% | – |
Q1 2019 | $5,000 | – | 581 | +1389.7% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 39 | -89.5% | 0.00% | – |
Q3 2018 | $5,000 | +400.0% | 370 | +85.0% | 0.00% | – |
Q2 2017 | $1,000 | – | 200 | +244.8% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 58 | -81.2% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 308 | +242.2% | 0.00% | – |
Q3 2015 | $1,000 | -83.3% | 90 | -85.9% | 0.00% | -100.0% |
Q1 2015 | $6,000 | -25.0% | 638 | -50.7% | 0.00% | 0.0% |
Q4 2014 | $8,000 | -57.9% | 1,294 | -33.4% | 0.00% | -50.0% |
Q2 2014 | $19,000 | +26.7% | 1,942 | +51.4% | 0.00% | 0.0% |
Q1 2014 | $15,000 | – | 1,283 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
Virtu Financial LLC | 31,633 | $13 | 0.00% |
Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
TSFG, LLC | 3,000 | $1 | 0.00% |
ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
Allworth Financial LP | 250 | $107 | 0.00% |
JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |